Abstract
The inhibitory effect of methotrexate on [3 H]deoxyuridine incorporation into DNA is reduced as the basal rate of this reaction is inhibited by pretreatment of Ehrlich ascites tumor cells with fluoropyrimidines. This observation is a basis for fluoropyrimidine-methotrexate antagonism in anticancer regimens and supports the concept that the sensitivity of thymidylate synthesis in tumor cells to methotrexate is related, in part, to the basal rate of thymidylate synthesis from deoxyuridylate.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 219-222 |
| Number of pages | 4 |
| Journal | Cancer research |
| Volume | 38 |
| Issue number | 1 |
| State | Published - Jan 1978 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Oncology
- Cancer Research
Fingerprint
Dive into the research topics of 'A Basis for Fluoropyrimidine-Induced Antagonism to Methotrexate in Ehrlich Ascites Tumor Cells in Vitro'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS